PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Molecular Endocrinology

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1530/JME-14-0118PMID 25125078
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of glucose transporters in cancers.

  2013cited by this paper
• Hypoxia-inducible factors in physiology and medicine.

  2012cited by this paper
• AMP-Activated Protein Kinase Upregulates Glucose Uptake in Thyroid PCCL3 Cells Independent of Thyrotropin

  2012cited by this paper
• Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas.

  2012cited by this paper
• Glucose Transporter 1 Expression, Tumor Proliferation, and Iodine/Glucose Uptake in Thyroid Cancer With Emphasis on Poorly Differentiated Thyroid Carcinoma

  2012cited by this paper
• Systemic elevation of PTEN induces a tumor-suppressive metabolic state.

  2012cited by this paper
• Thyroid cancer cell lines: an overview

  2012cited by this paper
• In vivo imaging of glucose uptake and metabolism in tumors

  2012cited by this paper
• Preliminary study on combined pharmacological and laser treatment in optic pit serous maculopathy after literature review.

  2012cited by this paper
• Loss of expression of the oncosuppressor PTEN in thyroid incidentalomas associates with GLUT1 plasmamembrane expression.

  2012cited by this paper
• The use of dual-phase 18F-FDG PET in characterizing thyroid incidentalomas.

  2011cited by this paper
• Thyroid incidentaloma identified by 18F‐fluorodeoxyglucose positron emission tomography with CT (FDG‐PET/CT): clinical and pathological relevance

  2011cited by this paper
• Otto Warburg's contributions to current concepts of cancer metabolism

  2011cited by this paper
• Otto Warburg's contributions to current concepts of cancer metabolism

  2011cited by this paper
• The Prognostic Value of 2-Deoxy-2-[18F]Fluoro-d-Glucose Positron Emission Tomography in Patients With Suspected Residual or Recurrent Medullary Thyroid Carcinoma

  2010influential reference
• The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors.

  2010cited by this paper
• P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.

  2009cited by this paper
• The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation

  2009cited by this paper
• FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0

  2009cited by this paper
• Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors.

  2008cited by this paper
• Aerobic glycolysis in cancers: Implications for the usability of oxygen‐responsive genes and fluorodeoxyglucose‐PET as markers of tissue hypoxia

  2008cited by this paper
• Cathepsin D-Bax death pathway in oxidative stressed neuroblastoma cells.

  2007cited by this paper
• In vitro studies on the signal transduction of thyroidal uptake of 18F-FDG and 131I-Iodide.

  2006cited by this paper
• Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D.

  2006cited by this paper
• Uptake of a Fluorescent Deoxyglucose Analog (2-NBDG) in Tumor Cells

  2005cited by this paper
• Glucose Transporters in the Thyroid

  2005cited by this paper
• Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death.

  2001cited by this paper
• Preoperative Diagnostic Value of [18F] Fluorodeoxyglucose Positron Emission Tomography in Patients With Radioiodine-Negative Recurrent Well-Differentiated Thyroid Carcinoma

  2001cited by this paper
• Loss of PTEN facilitates HIF-1-mediated gene expression.

  2000cited by this paper
• Glut-1 translocation in FRTL-5 thyroid cells: role of phosphatidylinositol 3-kinase and N-glycosylation.

  2000influential reference
• GLUT1 Glucose Transporter Expression in Benign and Malignant Thyroid Nodules

  1997cited by this paper
• The regulation of two distinct glucose transporter (GLUT1 and GLUT4) gene expressions in cultured rat thyroid cells by thyrotropin.

  1992cited by this paper
• [Glucose transporters].

  1990influential reference
• Thyroid autoregulation: effect of iodine on glucose transport in cultured thyroid cells.

  1986cited by this paper
• The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells

  1985cited by this paper

• Copy number amplification of FLAD1 promotes the progression of triple-negative breast cancer through lipid metabolism

  2025cites this paper
• Reprogramming of Thyroid Cancer Metabolism: from Mechanism to Therapeutic Strategy

  2025cites this paper
• N6-methyladenosine methyltransferase METTL3 facilitates the aerobic glycolysis of non-small cell lung cancer cells by activating the PI3K/AKT/mTOR pathway.

  2025cites this paper
• Exploring the clinical utility of DPP-IV and SGLT2 inhibitors in papillary thyroid cancer: a literature review

  2024cites this paper
• Flavonoids as modulators of metabolic reprogramming in renal cell carcinoma (Review)

  2024cites this paper
• Advances in traditional herbal formulation based nano-vaccine for cancer immunotherapy: Unraveling the enigma of complex tumor environment and multidrug resistance.

  2024cites this paper
• Atractylodes macrocephala Koidz. and Cuscuta chinensis Lam. extract relieves insulin resistance via PI3K/Akt signalling in diabetic Drosophila

  2024cites this paper
• Synthetic lethal approaches to target cancers with loss of PTEN function

  2023cites this paper
• Metabolic Deregulation in Pulmonary Hypertension

  2023cites this paper
• Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence

  2023cites this paper
• Reprogramming of Cellular Metabolism and Its Therapeutic Applications in Thyroid Cancer

  2022cites this paper
• GLUT1 and ASCT2 Protein Expression in Papillary Thyroid Carcinoma Patients and Relation to Hepatitis C Virus: A Propensity-Score Matched Analysis

  2022cites this paper
• Double Deletion of PI3K and PTEN Modifies Lens Postnatal Growth and Homeostasis

  2022cites this paper
• Metabolic reprogramming in renal cancer: Events of a metabolic disease.

  2021cites this paper
• Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy.

  2021cites this paper
• Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1 β activation on macrophages

  2021cites this paper
• A novel phenolic formulation for treating hepatic and peripheral insulin resistance by regulating GLUT4-mediated glucose uptake

  2021cites this paper
• Incidental thyroid uptake on PET scanning: epidemiology, clinical significance, and management challenge

  2021cites this paper
• POU2F2 regulates glycolytic reprogramming and glioblastoma progression via PDPK1-dependent activation of PI3K/AKT/mTOR pathway

  2021cites this paper
• Cytochrome C Oxidase Subunit 4 (COX4): A Potential Therapeutic Target for the Treatment of Medullary Thyroid Cancer

  2020cites this paper
• Regulators of glucose uptake in thyroid cancer cell lines

  2020cites this paper
• Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages

  2020cites this paper
• Physiological and Pathophysiological Roles of Ion Transporter-Mediated Metabolism in the Thyroid Gland and in Thyroid Cancer

  2020cites this paper
• Application program for wound healing measurement based on the region growing technique: A trial version

  2020cites this paper
• Physiological and Pathophysiological Roles of Ion Transporter-Mediated Metabolism in the Thyroid Gland and in Thyroid Cancer

  2020cites this paper
• The Role of the LY294002 - A Non-Selective Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) Pathway- in Cell Survival and Proliferation in Cell Line SCC-25

  2019cites this paper
• Hypoxia-induced pulmonary hypertension and chronic lung disease: caveolin-1 dysfunction an important underlying feature

  2019cites this paper
• Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs)

  2019cites this paper
• Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome

  2019cites this paper
• Overview of Positron-Emission Tomography Tracers for Metabolic Imaging

  2018cites this paper
• Targeting KRAS Mutant CMS3 Subtype by Metabolic Inhibitors.

  2018cites this paper
• Targeted Therapy of Colorectal Cancer Subtypes

  2018cites this paper
• The emerging co-regulatory role of long noncoding RNAs in epithelial-mesenchymal transition and the Warburg effect in aggressive tumors.

  2018cites this paper
• A novel genomic signature predicting FDG uptake in diverse metastatic tumors

  2018cites this paper
• Impairing energy metabolism in solid tumors through agents targeting oncogenic signaling pathways

  2018cites this paper
• DISC1 regulates lactate metabolism in astrocytes: implications for psychiatric disorders

  2018cites this paper
• Alteration of transporter activities in the epididymides of infertile initial segment-specific Pten knockout mice†

  2018cites this paper
• Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets

  2017cites this paper
• Antibody to human α-fetoprotein inhibits cell growth of human hepatocellular carcinoma cells by resuscitating the PTEN molecule: in vitro experiments.

  2017cites this paper
• Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches

  2017cites this paper
• PTEN dephosphorylates AKT to prevent the expression of GLUT1 on plasmamembrane and to limit glucose consumption in cancer cells

  2016cites this paper
• Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma.

  2016cites this paper
• Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression

  2015cites this paper
• Roles of facilitative glucose transporter GLUT1 in ( 18 F)FDG positron emission tomography (PET) imaging of human diseases

  2015cites this paper
• PTEN: Multiple Functions in Human Malignant Tumors

  2015cites this paper